LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 46.22 | 27.76 | 1237 | 4125 | 0.2999 | 0.6925 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 47.93 | 27.76 | 28 | 4421 | 0.0063 | 0.0012 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 47.93 | 27.76 | 1010 | 4421 | 0.2284 | 0.6345 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 47.93 | 27.76 | 110 | 4421 | 0.0249 | 0.2071 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 47.93 | 27.76 | 1240 | 4421 | 0.2805 | 0.6810 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 49.63 | 27.76 | 27 | 4818 | 0.0056 | -0.0037 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 49.63 | 27.76 | 1019 | 4818 | 0.2115 | 0.6231 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 49.63 | 27.76 | 124 | 4818 | 0.0257 | 0.2229 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 49.63 | 27.76 | 1262 | 4818 | 0.2619 | 0.6704 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 51.33 | 27.76 | 33 | 5117 | 0.0064 | 0.0232 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 51.33 | 27.76 | 1032 | 5117 | 0.2017 | 0.6167 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 51.33 | 27.76 | 135 | 5117 | 0.0264 | 0.2339 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 51.33 | 27.76 | 1249 | 5117 | 0.2441 | 0.6583 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.04 | 27.76 | 32 | 5365 | 0.0060 | 0.0189 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.04 | 27.76 | 1041 | 5365 | 0.1940 | 0.6116 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.04 | 27.76 | 271 | 5365 | 0.0505 | 0.3499 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.04 | 27.76 | 1263 | 5365 | 0.2354 | 0.6532 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 54.74 | 27.76 | 28 | 5606 | 0.0050 | 0.0011 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 54.74 | 27.76 | 1040 | 5606 | 0.1855 | 0.6051 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 54.74 | 27.76 | 702 | 5606 | 0.1252 | 0.5248 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 54.74 | 27.76 | 1297 | 5606 | 0.2313 | 0.6520 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 56.45 | 27.76 | 26 | 5745 | 0.0045 | -0.0085 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 56.45 | 27.76 | 1053 | 5745 | 0.1833 | 0.6042 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 56.45 | 27.76 | 838 | 5745 | 0.1459 | 0.5572 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 56.45 | 27.76 | 1332 | 5745 | 0.2318 | 0.6539 | MN20160318_Q01 | N12 |